STOCK TITAN

SenesTech, Inc. - SNES STOCK NEWS

Welcome to our dedicated page for SenesTech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on SenesTech stock.

SenesTech, Inc. (Nasdaq: SNES) is a pioneering biotechnology company based in the United States, specializing in the development of innovative fertility control solutions for managing animal pest populations. SenesTech is dedicated to improving global health through humane pest control methods, reducing the reliance on traditional lethal techniques.

The company’s flagship product, ContraPest®, is the first and only U.S. EPA-registered contraceptive for male and female rats. As a highly palatable liquid, ContraPest disrupts the reproductive cycle of Norway and roof rats, effectively reducing their populations. The product is dispensed inside tamper-resistant bait stations to minimize risks to non-target species and ensure the safety of handlers. ContraPest can be integrated into existing pest management programs or used as a standalone solution.

SenesTech's latest innovation, Evolve™, an EPA-designated minimum-risk contraceptive for rats, showcases the company's commitment to sustainable and humane pest control solutions. Evolve, available in a soft bait format, was launched in early 2024 and has already seen significant market acceptance. Its rapid adoption by distributors and end customers underscores its effectiveness in managing rodent populations by targeting their reproductive capabilities.

The company has expanded its reach by establishing distribution agreements with international partners, such as Agro Technic in Singapore, Evicom in Australia and New Zealand, and Q-chem in The Netherlands. These partnerships are pivotal in introducing SenesTech's fertility control solutions to new markets and enhancing global pest management strategies.

In addition to its product innovations, SenesTech has been recognized for its commercial achievements. The company was recently accepted as a vendor for Ace Hardware, allowing over 4,500 stores to order directly from SenesTech. Furthermore, SenesTech has launched a dedicated online store on Amazon, providing consumers and professionals with easy access to Evolve.

Financially, SenesTech reported record quarterly revenues in early 2024, driven by the rapid adoption of Evolve. The company's strategic initiatives, including the development of a contraceptive product for mice and operational efficiencies, are expected to sustain this growth trajectory.

SenesTech's mission is clear: to promote clean cities, efficient businesses, and happy households by providing humane, effective, and sustainable pest control solutions. For more information, visit SenesTech and ContraPest Store.

Rhea-AI Summary
SenesTech, Inc. (Nasdaq: SNES) announces the expansion of Evolve™ Soft Bait, the first and only soft bait contraceptive for rats, with substantial initial orders. The product targets rodent populations using non-lethal methods to restrict fertility, receiving enthusiastic demand and immediate orders. The expansion is a response to the success of ContraPest®, SenesTech's first fertility control product, with Evolve offering similar efficacy in a more user-friendly format. Legislators and regulators in New England are seeking to reduce or eliminate traditional poisons, presenting an opportunity for SenesTech's innovative solution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.28%
Tags
none
-
Rhea-AI Summary
SenesTech, Inc. (NASDAQ: SNES) announces EPA registration of ContraPest® products for sale in Puerto Rico, targeting rat overpopulation. The company is also finalizing plans with a large agricultural firm to be their lead customer in the country and working on product registration for Evolve™, a user-friendly non-liquid bait product. SenesTech offers four unique fertility control options to manage rat infestations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
none
-
Rhea-AI Summary
SenesTech, Inc. (NASDAQ: SNES) announced the closing of a public offering of 3,846,154 shares of its common stock and accompanying Series D and E warrants, generating approximately $5.0 million in gross proceeds. The net proceeds will be used for general corporate purposes, including research and development expenses, capital expenditures, working capital, and potential acquisitions or investments in businesses, products, and technologies. The offering was made pursuant to a registration statement on Form S-1 and was facilitated by H.C. Wainwright & Co.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
SenesTech, Inc. (SNES) announced the pricing of a public offering of 3,846,154 shares of its common stock and accompanying Series D and Series E warrants at a combined offering price of $1.30 per share. The Series Warrants have an exercise price of $1.30 per share and will be immediately exercisable upon issuance. The Series D Warrants will expire five years following the initial exercise date, and the Series E Warrants will expire eighteen months following the initial exercise date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-50.53%
Tags
-
Rhea-AI Summary
SenesTech, Inc. (SNES) announced the launch of Evolve™ Soft Bait at Ace Hardware franchise locations in California. The product targets rodent populations using nonlethal methods to restrict fertility, marking the first time a traditional retail store has offered SenesTech's rodent fertility control solutions. Evolve is designed to reduce or eliminate the fertility of rats, offering diverse placement in different environments and competitive pricing compared to rodenticide alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-50.53%
Tags
none
-
Rhea-AI Summary
SenesTech, Inc. (NASDAQ: SNES) renews and expands distribution with DIY Pest Control, stocking order for Evolve™ Soft Bait. The product targets rodent populations using nonlethal methods to restrict fertility. Evolve is highly palatable to rats, easy to deploy, and offers diverse placement in various environments. DIY Pest Control expresses excitement about adding Evolve to their offerings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.92%
Tags
none
News
Rhea-AI Summary
SenesTech, Inc. (SNES) announces a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares, effective on November 17, 2023. This decision was made following a special meeting of stockholders held on August 18, 2023, where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split. The split will reduce the number of issued shares from 5,899,060 shares to approximately 491,589 shares, and proportional adjustments will be made to the number of shares of the Company's common stock issuable upon exercise or conversion of SenesTech's equity awards and warrants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
-
Rhea-AI Summary
SenesTech, Inc. (NASDAQ: SNES) announced a 44% year-over-year revenue growth and a nearly $700,000 improvement in net loss for Q3 2023. The company is set to begin shipments of Evolve Soft Bait next week, which is expected to drive further revenue growth. The launch of Evolve is a significant step in expanding SenesTech's reach within key market verticals, including big box retailers, e-commerce channels, and pest management professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-31.12%
Tags
-
Rhea-AI Summary
SenesTech, Inc. (NASDAQ: SNES) will release its financial results for the third quarter of 2023 on November 9, 2023, after the market close. A conference call to review the results will be held on the same day at 5:00 pm ET. Interested parties can access the call via dial-in or live webcast. Replay options will be available for both the teleconference and webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
conferences earnings
Rhea-AI Summary
SenesTech, Inc. is now taking orders for Evolve Soft Bait, a solution designed to reduce fertility in rats. The product targets the root cause of pest problems by controlling the fertility of rats. It is highly palatable, easy to deploy, and can be used in various environments. Evolve is priced competitively to rodenticide alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none

FAQ

What is the current stock price of SenesTech (SNES)?

The current stock price of SenesTech (SNES) is $2.93 as of December 20, 2024.

What is the market cap of SenesTech (SNES)?

The market cap of SenesTech (SNES) is approximately 2.9M.

What is SenesTech, Inc.?

SenesTech, Inc. is a United States-based biotech company specializing in humane pest control solutions through fertility control. Their flagship products include ContraPest® and Evolve™.

What products does SenesTech offer?

SenesTech offers ContraPest, the first U.S. EPA-registered contraceptive for rats, and Evolve, an EPA-designated minimum-risk contraceptive for rats.

How does ContraPest work?

ContraPest works by targeting the reproductive cycle of Norway and roof rats, effectively reducing their fertility and population levels. It is dispensed in tamper-resistant bait stations to ensure safety.

What are the benefits of using Evolve?

Evolve is a soft bait contraceptive that reduces rodent fertility, offering a humane and effective alternative to traditional lethal methods. It fits seamlessly into integrated pest management programs.

Who are SenesTech’s distribution partners?

SenesTech has distribution agreements with partners like Agro Technic in Singapore, Evicom in Australia and New Zealand, and Q-chem in The Netherlands.

Where can I purchase SenesTech products?

SenesTech products can be purchased through their website, the ContraPest Store, Amazon, and through various retail and distribution partners including Ace Hardware.

What is the financial outlook for SenesTech?

SenesTech reported record quarterly revenues in early 2024, driven by the rapid adoption of Evolve. The company continues to focus on commercial growth and operational efficiencies.

What makes SenesTech's products unique?

SenesTech's products are unique because they target the reproductive cycle of pests, providing a humane and effective alternative to lethal pest control methods.

Are SenesTech’s products safe for non-target species?

Yes, ContraPest is dispensed inside tamper-resistant bait stations to minimize risks to non-target species and ensure handler safety.

What is SenesTech's mission?

SenesTech's mission is to promote clean cities, efficient businesses, and happy households by providing humane, effective, and sustainable pest control solutions.

SenesTech, Inc.

Nasdaq:SNES

SNES Rankings

SNES Stock Data

2.86M
1.03M
0.02%
1.89%
4.64%
Specialty Chemicals
Agricultural Chemicals
Link
United States of America
PHOENIX